Quest Diagnostics Inc - Company Profile
Powered by 
All the sales intelligence you need on Quest Diagnostics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Quest Diagnostics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Quest Diagnostics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Quest Diagnostics Inc (Quest Diagnostics) is a healthcare company engaged in providing diagnostic information services to patients and physicians through a network of laboratories and company-owned patient service centers. It offers an array of services, including clinical testing with gene-based and other esoteric tests, anatomic pathology services, clinical trial testing, life insurer services, and various healthcare information technology and diagnostic products. The company's products and services are utilized by physicians, hospitals, patients, health plans, and government agencies across various healthcare sectors. Quest Diagnostics operates through a network of laboratories and patient service centers. The company has operations in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Secaucus, New Jersey, the US.
Headquarters
United States of America
Address
500 Plaza Drive, Secaucus, New Jersey, 07094
Website
www.questdiagnostics.com
Telephone
1 973 5202700
No of Employees
46,000
Industry
Medical Equipment
Ticker Symbol & Exchange
DGX (NYSE)
Revenue (2024)
$11.0B
6.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
2%
(2024 vs 2023)
Market Cap*
$20.7B
Net Profit Margin (2023)
XYZ
-4.4%
(2024 vs 2023)
* As of and is in US$
Quest Diagnostics Inc premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Diagnostic Testing Services | AmeriPath |
| Clinical Trials | Athena |
| Anatomic Pathology Services | AccuType |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | New Products/Services | In September, the company launched an advanced pharmacogenomic laboratory test service. |
| 2025 | Others | In September, the company announced to work with Epic to provide a suite of technologies and services to act as the foundation for Project Nova. |
| 2025 | Contracts/Agreements | In September, the company collaborated with WHOOP for in-app clinical lab testing and results through the new WHOOP Advanced Labs. |
Competitor Comparison
| Key Parameters | Quest Diagnostics Inc | Thermo Fisher Scientific Inc | Labcorp Holdings Inc | Novant Health Inc | Bio-Rad Laboratories Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Secaucus | Waltham | Burlington | Charlotte | Hercules |
| State/Province | New Jersey | Massachusetts | North Carolina | North Carolina | California |
| No. of Employees | 46,000 | 125,000 | 71,000 | - | 7,450 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| James E. Davis | Chairman; Chief Executive Officer; President | Executive Board | 2023 | 63 |
| Sam A. Samad | Chief Financial Officer; Executive Vice President | Senior Management | 2022 | 56 |
| Benjamin Beauvalot | Chief M&A Officer; Chief Strategy Officer; Senior Vice President | Senior Management | 2025 | - |
| Kristin Wallace | Chief Compliance Officer; Senior Vice President | Senior Management | 2022 | - |
| Yuri A. Fesko, MD | Chief Medical Officer; Senior Vice President | Senior Management | 2023 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer